01 1Ipca Laboratories
01 1CARVEDILOL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-19
Pay. Date : 2012-11-13
DMF Number : 20930
Submission : 2007-10-18
Status : Active
Type : II
20
Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CARVEDILOL USP, with a corresponding US DMF Number 20930.
Remarkably, this DMF maintains an Active status since its submission on October 18, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 19, 2013, and payment made on November 13, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
